EXPAREL Indicated for Administration Into Surgical Site to Produce Postsurgical Analgesia

Pacira Pharmaceuticals, a specialty pharmaceutical company, has launched EXPAREL (bupivacaine liposome injectable suspension) in the US.

EXPAREL is indicated for administration into the surgical site to produce postsurgical analgesia.

The product combines bupivacaine with DepoFoam, a product delivery technology that delivers medication over a desired time period.

Pacira president and CEO Dave Stack said: "For the millions of patients undergoing surgical procedures in the U.S. each year, the introduction of EXPAREL--a single-dose, non-opioid local analgesic given at the close of surgery--represents a significant addition to the armamentarium of currently available options to manage postsurgical pain."